Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CLOVER HEALTH INVESTMENTS, CORP. (CLOV)
|
|
| Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 8-K | 10-K | 10-K | 10-K |
| Corporate/Other | | 41.9 | | |
| Other | | 1,430.1 | | |
| Total revenues | 3,476.7 | 1,472.0 | 672.9 | 462.3 |
| Revenue growth | 136.2% | 118.8% | 45.6% | |
| Other operating expenses | 3,814.2 | 2,056.5 | 773.3 | 802.8 |
| General and administrative | 207.9 | 445.7 | 192.1 | 187.3 |
| EBITDA | | -636.8 | -92.9 | -186.1 |
| EBITDA margin | | -43.3% | -13.8% | -40.2% |
| Depreciation | | 0.2 | -0.2 | -2.9 |
| EBIT | -370.9 | -637.0 | -92.7 | -183.2 |
| EBIT margin | -10.7% | -43.3% | -13.8% | -39.6% |
| Interest income, net [+] | -1.3 | -58.9 | -129.7 | 249.6 |
| Interest expense | 1.3 | 3.2 | 36.0 | 23.2 |
| Interest income | | -55.7 | -93.8 | 272.8 |
| Pre-tax income | -338.8 | -587.8 | -136.4 | -363.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -338.8 | -587.8 | -136.4 | -363.7 |
| Net margin | -9.7% | -39.9% | -20.3% | -78.7% |
| |
| Basic EPS | | ($1.42) | ($1.54) | ($4.14) |
| Diluted EPS | | ($1.42) | ($1.54) | ($4.14) |
| |
| Shares outstanding (basic) | | 412.9 | 88.7 | 87.8 |
| Shares outstanding (diluted) | | 412.9 | 88.7 | 87.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|